指南与共识流行病学与生物统计医学教育与科研方法

面部老化临床试验核心结局指标集的开发:系统文献综述与德尔菲调查识别核心结局指标集的研究方案

Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
指南 / 共识 · Trials · 2017-08-01

本方案拟通过系统医学文献综述、患者访谈、其他已发表来源及利益相关方参与四种途径生成可测量结局的长清单,经两轮医生与患者同质组的德尔菲流程及共识会议投票,最终形成面部老化临床试验推荐的核心结局指标集,并据此选择或创建相应测量工具。

要点

  • 面部老化临床试验结局指标存在异质性,限制了治疗方式的评估与比较质量。
  • 将从系统文献综述、患者访谈、其他已发表来源及利益相关方参与四种来源生成可测量结局长清单。
  • 经两轮德尔菲流程及共识会议投票形成推荐的核心结局指标集,并选择或创建相应测量工具。

核心结论

  • 本研究旨在为面部老化相关临床试验制定核心结局指标集及相关测量工具,希望提高皮肤老化结局报告的可靠性与一致性,从而改善对治疗效果和患者满意度的评估。

研究设计与样本

  • 研究方案将首先从系统医学文献综述、患者访谈、其他已发表来源及利益相关方参与四种来源生成可测量结局的长清单。
  • 随后由医生与患者的同质组进行两轮德尔菲流程,对清单进行优先排序和精简。
  • 在由医生、患者及利益相关方参加的共识会议上,依据参与者评分进一步精简结局,并通过投票决定最终推荐的核心结局指标集。
  • 此后将选择或创建具体测量工具以评估这些结局。
  • 方案版本日期为2016年7月28日,已在COMET倡议和CSG-COUSIN注册。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Facial aging is a concern for many patients. Wrinkles, loss of volume, and discoloration are common physical manifestations of aging skin. Genetic heritage, prior ultraviolet light exposure, and Fitzpatrick skin type may be associated with the rate and type of facial aging. Although many clinical trials assess the correlates of skin aging, there is heterogeneity in the outcomes assessed, which limits the quality of evaluation and comparison of treatment modalities. To address the inconsistency in outcomes, in this project we will develop a core set of outcomes that are to be evaluated in all clinical trials relevant to facial aging. METHODS/DESIGN: A long list of measureable outcomes will be created from four sources: (1) systematic medical literature review, (2) patient interviews, (3) other published sources, and (4) stakeholder involvement. Two rounds of Delphi processes with homogeneous groups of physicians and patients will be performed to prioritize and condense the list. At a consensus meeting attended by physicians, patients, and stakeholders, outcomes will be further condensed on the basis of participant scores. By the end of the meeting, members will vote and decide on a final recommended set of core outcomes. Subsequent to this, specific measures will be selected or created to assess these outcomes. DISCUSSION: The aim of this study is to develop a core outcome set and relevant measures for clinical trials relevant to facial aging. We hope to improve the reliability and consistency of outcome reporting of skin aging, thereby enabling improved evaluation of treatment efficacy and patient satisfaction. TRIAL REGISTRATION: Core Outcome Measures in Effectiveness Trials (COMET) Initiative, accessible at http://www.comet-initiative.org/studies/details/737 . Core Outcomes Set Initiative, (CSG-COUSIN) accessible at https://www.uniklinikum-dresden.de/de/das-klinikum/universitaetscentren/zegv/cousin/meet-the-teams/project-groups/core-outcome-set-for-the-appearance-of-facial-aging . Protocol version date is 28 July 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Schlessinger DI, Iyengar S, Yanes AF, et al. Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2017. PMID: 28764734. doi:10.1186/s13063-017-2104-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。